News

Falcon Oil & Gas Provides Insight on Shenandoah Pilot Project

Falcon Oil & Gas Provides Insight on Shenandoah Pilot Project

Update from Falcon Oil & Gas Ltd.

Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) is excited to share notable updates regarding its operational activities, with particular focus on the ongoing stimulation campaign and key developments in the Shenandoah South Pilot Project.

Commencement of Flow Testing

Recently, Falcon Oil & Gas has noted significant advancements following announcements from Tamboran Resources Corporation. The initiation of flow testing in the Shenandoah S2-2H ST1 well marks an important milestone in the Beetaloo Sub-basin endeavor.

Details on the Flow Testing at SS-2H ST1

The flow testing at SS-2H ST1 has commenced after an extensive soaking period, enabling water absorption into the rock. This process enhances the formation's permeability to gas, setting the stage for productive outcomes in the coming months.

The Initial Production over 30 days (IP30) results are anticipated to be publicly available by mid-next month, with testing projected to continue for a full 90 days, barring any unforeseen circumstances.

Checkerboard Acreage Agreement

In line with the recent agreements, Falcon Oil & Gas and Daly Waters Energy, LP have solidified a checkerboard arrangement concerning exploration permits. Both entities will operate working interest areas, with Falcon retaining a notable non-operating interest.

Implications for Falcon Oil & Gas

This agreement positions Falcon strategically across all checkerboard segments, maintaining its critical role within the joint venture. Specifically, Falcon is noted for its 5% interest in the northern Pilot Area, which is pivotal for initial gas production.

Funding and Completion of the Shenandoah South Pilot Project

Funding progress has also been confirmed for the completion of the Shenandoah South Pilot Project. Following a successful fundraising initiative by Tamboran, plans are underway to drill and complete three additional wells at the site.

Notably, Falcon has opted to modify its stake, withdrawing its interests in these three upcoming wells, a decision reflecting the company’s strategic approach to managing expenditures while aiming for success in the region.

Valuation Insights

The recent agreements have sparked interest in asset valuations, with the transaction between DWE and Tamboran suggesting a valuation of approximately US$150 million for Falcon's acreage at a minimum price of US$150 per acre.

Investor Engagement Opportunity

To enhance investor engagement, CEO Philip O’Quigley will host a Q&A session via the Investor Meet Company platform, offering a platform for discussions related to these recent developments. Investors are encouraged to participate and submit their inquiries in advance of the event.

Looking Ahead

As Falcon Oil & Gas Ltd. continues to navigate its operational landscape, the focus will remain on extracting value from its extensive holdings, leveraging partnerships to maximize output, and strategically managing resources to secure long-term sustainability in its operations.

The company's interest remains clear, as it is positioned to support the overall success of the Beetaloo project while remaining responsive to market dynamics.

Frequently Asked Questions

What is the significance of the SS-2H ST1 flow testing?

The SS-2H ST1 flow testing is significant as it marks a critical step in evaluating gas production potential in the Beetaloo Sub-basin, which is pivotal for Falcon's operational strategy.

How will Falcon Oil & Gas be involved in future wells?

Falcon has decided to withdraw its interest in the next three wells, focusing on capital preservation while maintaining a steady interest in its remaining assets.

What opportunities exist for investors to engage with Falcon?

Investors can engage with Falcon during the Q&A session hosted by CEO Philip O’Quigley, which is designed to address inquiries about the company’s strategic direction and recent developments.

What are the expected outcomes from the Shenandoah South Pilot Project?

The project aims to deliver first gas by mid-2026, contingent on successful drilling and completion of planned wells.

How does Falcon's interest in the project compare to its partners?

Falcon maintains a unique position by having stakes across all joint venture components, signifying its integrated role in the project's success, even as it adjusts its direct operating interests.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 9

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 6

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors in Light & Wonder, Inc. Urged to Act on Rights

Updated Category News Views 154

Light & Wonder, Inc. Investor Rights and Action Steps In a recent development, the Rosen Law Firm has taken the initiative to investigate potential securities claims for shareholders of Light & Wonder, Inc. If you have invested in Light & Wonder (NASDAQ: LNW), it is crucial to be informed about the ongoing legal matters that could impact your investments. Understanding...

Continue Reading
Exciting New Roaming Trails RV Community Launch in Texas

Updated Category News Views 170

Exciting New Roaming Trails RV Community Launch in Texas New gated RV destination brings elevated long-term stays to the Fort Worth metro area Provident is thrilled to unveil the grand opening of Roaming Trails RV Retreat, a new gated RV community located just south of Fort Worth. Set to commence operations on November 1, this marks Provident's first entry into the...

Continue Reading
Innovative Device Enhances At-Home Medical Exam Experience

Updated Category News Views 258

Revolutionizing Self-Exams with Innovative Design In today's fast-paced world, health awareness is more crucial than ever. Individuals often seek ways to monitor their health conveniently from the comfort of their home. Recognizing this need, an inventive mind has developed a unique device aimed at simplifying personal health examinations. The MEDICAL EXAM WAIST BAND...

Continue Reading
Emerita Resources Outlines Strategic Response to Aznalcollar Project Developments

Updated Category News Views 179

Emerita Resources Addresses New Developments in Aznalcollar Project Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) recently commented on significant changes regarding the Aznalcollar project in Spain. The Ministry of Energy and Mines announced that they have granted an exploitation license to Minera Los Frailes (MLF) to advance the project, but there are...

Continue Reading
Arvinas Unveils Promising Data for Its Cancer Treatment ARV-393

Updated Category News Views 219

Exciting Advances in Cancer Treatment by Arvinas Arvinas, Inc. (Nasdaq: ARVN), a groundbreaking biotechnology company focused on novel drug development through targeted protein degradation, has exciting news for the cancer research community. The company recently announced that promising preclinical combination data for its investigational drug ARV-393 will be showcased...

Continue Reading